Skip to content

Evaluation of the Safety and Efficacy of Radical Surgery for Single Position Ureteroperopel Cancer: A Multicenter Retrospective Cohort Study Based on Propensity Score Matching

Evaluation of the Safety and Efficacy of Radical Surgery for Single Position Ureteroperopel Cancer: A Multicenter Retrospective Cohort Study Based on Propensity Score Matching

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090932
Enrollment
Unknown
Registered
2024-10-16
Start date
2024-10-19
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal pelvic cancer, ureteral cancer

Interventions

Radical resection of single position pyeloureteral cancer (exposure group):Radical surgery for single position ureteroperoperoid tumors
Radical resection of traditional pyeloureteral cancer (control group):Radical surgery for traditional ureteroperoperoid tumors

Sponsors

The Second Affiliated Hospital of the Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Imaging (ultrasound, abdominal CT, etc.) to diagnose cases of renal pelveropelvic tumors; 2. Ureteroscopic biopsy diagnosed as a case of pyeloureteral cancer; 3. The treatment method is radical resection of renal pelveropelvic tumor.

Exclusion criteria

Exclusion criteria: 1. The data cannot be viewed or unknown cases are recorded; 2. Combined with bladder tumors, combined with bladder tumor resection; 3. Combined with bladder tumors, combined with radical total bladder resection; 4. Intraoperative uterine or adnexectomy.

Design outcomes

Primary

MeasureTime frame
Duration of surgery;

Secondary

MeasureTime frame
Tumor recurrence time ;Amount of bleeding;Preoperative and postoperative GFR changes;Mean length of hospital stay postoperatively;Time to recovery of bowel function after surgery;Postoperative complications;Total number of days in hospital;

Countries

China

Contacts

Public ContactFang Zhenqiang

The Second Affiliated Hospital of the Army Medical University

fang123zq@163.com+86 138 8328 6478

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026